Symphony Allegro
-
2006
Company Description
Biopharmaceutical Company
Symphony Allegro is supporting the advancement of AZ-004 through Phase III clinical trials for the treatment of acute agitation in patients with schizophrenia and bipolar disorder, AZ-104 through Phase IIa clinical trials for the treatment of migraine, and AZ-002 through Phase IIb clinical trials for the treatment of panic attack in patients with panic disorder.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Company Website:
-
Company E-mail:
-
Company Address:
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits